These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1838799)

  • 1. Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer's disease.
    O'Neill C; Cowburn RF; Wiehager B; Alafuzoff I; Winblad B; Fowler CJ
    Neurosci Lett; 1991 Nov; 133(1):15-9. PubMed ID: 1838799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
    Harrington MA; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
    Hashimoto T; Nishino N; Nakai H; Tanaka C
    Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHAPS solubilization of a G-protein sensitive 5-HT1A receptor from bovine hippocampus.
    Kline T; Park H; Meyerson LR
    Life Sci; 1989; 45(21):1997-2005. PubMed ID: 2532283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
    J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
    Kitamura Y; Imai S; Matsueda R; Nomura Y
    Mol Pharmacol; 1990 Aug; 38(2):184-91. PubMed ID: 2166901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
    Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling of human brain cerebral cortical alpha 2-adrenoceptors to GTP-binding proteins in Alzheimer's disease.
    O'Neill C; Fowler CJ; Wiehager B; Cowburn RF; Alafuzoff I; Winblad B
    Brain Res; 1991 Nov; 563(1-2):39-43. PubMed ID: 1664776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K; Titeler M
    J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.
    Palego L; Marazziti D; Rotondo A; Batistini A; Lucacchini A; Naccarato AG; Bevilacqua G; Borsini F; Ladinsky H; Cassano GB
    Neurochem Int; 1997 Feb; 30(2):149-57. PubMed ID: 9017662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
    Chamberlain J; Offord SJ; Wolfe BB; Tyau LS; Wang HL; Frazer A
    J Pharmacol Exp Ther; 1993 Aug; 266(2):618-25. PubMed ID: 8355195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered G-protein coupling of a frontal cortical low affinity [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin serotonergic binding site in Alzheimer's disease.
    Weinstein D; Magnuson D; Lee J
    Behav Brain Res; 1996; 73(1-2):325-9. PubMed ID: 8788528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).
    el Mestikawy S; Cognard C; Gozlan H; Hamon M
    J Neurochem; 1988 Oct; 51(4):1031-40. PubMed ID: 2971097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
    Iben LG; Mahle CD; Yocca FD
    Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins.
    Emerit MB; el Mestikawy S; Gozlan H; Rouot B; Hamon M
    Biochem Pharmacol; 1990 Jan; 39(1):7-18. PubMed ID: 2136995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW; Eastwood SL; Harrison PJ
    Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.